Joaquina Baranda - Dissemin

All papers authored by Joaquina Baranda

This paper is made freely available by the publisher.

2024 Antonio Giordano, Arif Ali Ali Awan, Justine Yang Bruce, Hope S. Rugo, Jennifer Robinson Diamond, Yelena Novik, Joaquina Celebre Baranda

, Kei Muro, Makiko Ono, Rita Nanda, Jason Kaplan, Seema Rao Gorla, Shubin Liu, Michele Wozniak, Anthony Lee and 1 other authors

Enfortumab vedotin (EV) in triple-negative breast cancer (TNBC) and HR+/HER2- breast cancer (BC) cohorts of EV-202.

Download from doi.org

Kei Muro, Trevor Feinstein, Joaquina Celebre Baranda

, Ioana Bonta, Satoru Kitazono, Todd A. Gersten, Leena Gandhi, Toshihiro Kudo, Jason Kaplan, Seema Rao Gorla, Shubin Liu, Michele Wozniak, Anthony Lee, Tejas Patil

Enfortumab vedotin (EV) in non-squamous and squamous non–small cell lung cancer (NSCLC) cohorts of EV-202.

Download from doi.org

Thatcher Ross Heumann, Shannon Stockton, Michael Cecchini, Raid Aljumaily, Cathy Shyr, Jennifer Whisenant, Jason S. Starr, Farshid Dayyani, Joaquina Celebre Baranda

, Nikolaos Trikalinos, S. Percy Ivy, Patricia LoRusso, Satya Das, Steven Gore, Jan Hendrik Beumer and 1 other authors

A phase I study of irinotecan combined with BAY1895344 (ATR inhibitor) in advanced solid tumors: Results of ETCTN 10402 dose escalation.

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Joaquina Baranda

Enfortumab vedotin (EV) in previously treated gastric/esophageal cancers cohorts of EV-202

Upload

Anup Kasi, Raed Moh'd Taiseer Al-Rajabi, Anwaar Saeed, Weijing Sun, Joaquina Celebre Baranda

, Haoran Li, Jo Wick, Sanjana Mullangi, Kenda Eberhardt, Shannon Bradbury, Rebecca Romero, Erin Carroll, Lori Barbosa, Mazin Francis Al-Kasspooles

Association of circulating DNA with recurrence in CRS-HIPEC patients with colorectal and appendiceal peritoneal carcinomatosis: Insights from a phase II randomized trial.

Download from doi.org

William Wesson, Fathima Shehnaz Ayoobkhan, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Al-Ola A. Abdallah, Weijing Sun, Faiz Anwer, Gary C. Doolittle, Joseph McGuirk, Raed Moh'd Taiseer Al-Rajabi, Joaquina Celebre Baranda

, Nausheen Ahmed

Characterizing clinical trials for CAR T targeting solid tumors from 2018 to 2023: A systematic review.

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Alice N. Weaver, Wade T. Iams, Jong Chul Park, Monica Mita, Udo Holtick, Michael S. Gordon, Kerry J. Rodabaugh, Neesha Dhani, Prakash Neupane, Matthew Taylor, E. Amanda Duvall, Julia Jennings, Nathan R. Miselis, Scott Loughhead, Marshelle S. Warren and 4 other authors

Final outcomes analysis of the cell product SQZ‐PBMC‐HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration

Upload

Aroog Khaliq

, William Wesson

, Emerson Logan, Carine Tabak

, Muhammad Umair Mushtaq

, Tara Lin, Joaquina Baranda

, Leyla Shune, Al-Ola Abdallah, Joseph McGuirk

, Mehdi Hamadani, Nausheen Ahmed

The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma

Upload

Anwaar Saeed

, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour

, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Baranda

, Weijing Sun

, Stephen Williamson

, Yu-Chiao Chiu

, Hatice Ulku Osmanbeyoglu

, Rashna Madan, Hassan Abushukair

and 3 other authors

Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort

Download from doi.org

Anwaar Saeed, Robin Park, Junqiang Dai, Anup Kasi, Lori Barbosa, Kelly Mulvaney, Jordan Rarden, Milind A. Phadnis, Azhar Saeed, Ibrahim Halil Sahin, Joaquina Celebre Baranda

, Stephen K. Williamson, Weijing Sun, Raed Moh'd Taiseer Al-Rajabi

Phase II trial of cabozantinib (cabo) plus durvalumab (durva) in chemotherapy refractory microsatellite stable (MSS) patients with advanced gastric and esophageal (G/E) adenocarcinoma: CAMILLA G/E cohort results.

Download from doi.org

Anup Kasi, Milind A. Phadnis, Raed Moh'd Taiseer Al-Rajabi, Joaquina Celebre Baranda

, Haoran Li, Erin Carroll, Cathey Belcher, Shannon Bradbury, Zachary Collins, Weijing Sun

A phase II open-label study of enfortumab vedotin in patients with previously treated locally advanced, recurrent, or metastatic pancreatic adenocarcinoma (EPIC).

Download from doi.org

Raed Moh'd Taiseer Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda

, Anwaar Saeed, Haoran Li, Collin Bruey, Shaun Best, Milind A. Phadnis, Weijing Sun

Phase I/II clinical trial of regorafenib plus durvalumab (MEDI4736) in patients with chemotherapy-refractory advanced biliary tract cancers.

Download from doi.org

Salman Rafi Punekar, Meredith Pelster, Carlos Roberto Becerra, J. Randolph Hecht, Andrew Scott Paulson, Patrick Grierson, Maria Pia Morelli, Rom Leidner, Mandana Kamgar, Joaquina Celebre Baranda

, Syed Mohammad Ali Kazmi, Ardaman Shergill, Anne M. Robinson, Anuradha Patel, Ying Yan and 5 other authors

An open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-112 in human leukocyte antigen-C*08:02–positive adult patients with unresectable, advanced, and/or metastatic solid tumors that are positive for the KRAS G12D mutation.

Upload

2023 Joaquina C. Baranda

Abstract IA029: Expanding access and participation to early phase clinical trials for our underrepresented populations

Upload

Ian M. Freed

, Anup Kasi, Oluwadamilola Fateru, Mengjia Hu, Phasin Gonzalez, Nyla Weatherington, Harsh Pathak, Stephen Hyter, Weijing Sun

, Raed Al-Rajabi, Joaquina Baranda

, Mateusz L. Hupert, Prabhakar Chalise

, Andrew K. Godwin

, Malgorzata A. Witek and 1 other authors

Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients

Download from doi.org

Weijing Sun

, Nirmal Veeramachaneni, Raed Al‐Rajabi, Rashna Madan, Anup Kasi, Mazin Al‐Kasspooles, Joaquina Baranda

, Anwaar Saeed, Milind A. Phadnis, Andrew K. Godwin, Mojtaba Olyaee, Natalie Streeter, Alykhan Nagji, Junqiang Dai, Stephen Williamson

A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma

Download from doi.org

Qamar J. Khan, Colleen Bohnenkamp, Taylor Monson, Holly E. Smith, Milind A. Phadnis, Vinay Raja, Manana Elia, Anne O'Dea, Gregory James Crane, Mark Robert Fesen, Lauren Elizabeth Nye, Maureen Sheehan, Robert E. Pluenneke, Raed Moh'd Taiseer Al-Rajabi, Joaquina Celebre Baranda

and 5 other authors

Randomized trial of fixed dose capecitabine compared to standard dose capecitabine in metastatic breast cancer: The X-7/7 trial.

Download from doi.org

Nausheen Ahmed, William Wesson, Dinesh Pal Mudaranthakam, Muhammad Umair Mushtaq, Al-Ola A. Abdallah, Forat Umair Lutfi, Joaquina Celebre Baranda

, Sunil H. Abhyankar, Joseph McGuirk, Marc Hoffmann

Rural communities and health professional shortage areas (HPSA) and access to immune effector cellular therapy and lymphoma/myeloma clinical trials.

Download from doi.org

Anup Kasi, Junqiang Dai, Raed Moh'd Taiseer Al-Rajabi, Joaquina Celebre Baranda

, Anwaar Saeed, Prabhakar Chalise, Erin Carroll, Shannon Bradbury, Stephen Hyter, Malgorzata Anna Witek, Venkatadri Beeki, Richard J. McKittrick, Manidhar Reddy Lekkala, Anusha Chidharla, Sean Kumer and 5 other authors

Targeting germline or somatic DNA repair defects (beyond BRCA) in pancreatic cancer with niraparib: A phase II study (NIRA-PANC).

Download from doi.org

Anup Kasi, Francisco Diaz, Raed Moh'd Taiseer Al-Rajabi, Joaquina Celebre Baranda

, Erin Carroll, Cathey Belcher, Mojtaba Olyaee, Amit Rastogi, Timothy Schmitt, Sean Kumer, Atta Nawabi, Harsh B. Pathak, Andrew K. Godwin, Mary Markiewicz, Weijing Sun

Targeting minimal residual disease (MRD) in resected RAS mutated pancreatic cancer with vaccine TG01/QS-21 +/- PD-1 inhibitor, balstilimab: A randomized phase II study (TESLA).

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Joaquina Baranda